Position in EBS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,724,841
+$510,526 QoQ
Shares Held
1,041,151
+5.2% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 194 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. EBS ranks #16 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in EBS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,724,841 | 1,041,151 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $8,214,315 | 989,677 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $5,908,436 | 478,029 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,170,686 | 586,246 | Shares | Other | 2025-11-14 | |
| 2024-06-30 | $3,139,320 | 460,311 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,660,794 | 1,051,698 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $1,232,197 | 513,416 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $609,001 | 179,118 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $757,865 | 103,111 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,097,060 | 202,419 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,485,189 | 549,127 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,265,845 | 250,874 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,558,394 | 114,639 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,529,148 | 85,951 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,539,385 | 495,500 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,181,067 | 363,113 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $42,472,834 | 674,279 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $34,082,546 | 366,834 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,315,084 | 182,088 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,477,936 | 53,014 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,838,555 | 73,831 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $4,213,654 | 72,825 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||